Drugs / HIV Vaccine 732462
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01218113 | Nov 2010 → Nov 2012 | AIDS | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HIV Vaccine 732462 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01218113 ↗ |
| Modality | Vaccine | “HIV Vaccine 732462” NCT01218113 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT01218113 ↗ |